Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print West Nile Virus Infection Greater Than Previously Thought (pp 254, 261)

West Nile Virus Infection Greater Than Previously Thought (pp 254, 261)

July 25, 2001

A detailed analysis of the 1999 New York City outbreak of West Nile virus suggests that a substantial - and previously undiagnosed - outbreak of West Nile fever accompanied the 59 cases of West Nile meningoencephalitis, in which seven people died. The authors of the study, which is published in this week's issue of THE LANCET, conclude that for every diagnosed case of meningoencephalitis, there were likely to be 140 other infections, including 30 individuals with an influenza-like illness

In the summer of 1999, West Nile virus was recognised in the western hemisphere for the first time, when it caused an epidemic of encephalitis and meningitis in New York City, NY, USA. Intensive hospital-based surveillance identified 59 cases, including seven deaths in the region. Farzad Mostashari and colleagues from the New York City Department of Health and the Centers for Disease Control and Prevention, USA, did a household-based survey in October, 1999 (around six weeks after the peak of the outbreak). They assessed more clearly the public-health impact of the epidemic, its range of illness, and risk factors associated with infection.




The investigators used a representative sample of households in an area of about 7.3 km2 at the outbreak epicentre. Blood samples were tested for antibodies specific for West Nile virus. 677 individuals from 459 households took part in the survey. 19 (2.6%) were seropositive (ie, they had the virus confirmed by blood test); a third of these individuals (32%) reported a recent febrile illness, compared with 70 of 648 (11%) who were seronegative.

A febrile syndrome with fatigue, headache, muscle pain, and painful joints was highly associated with seropositivity. By extrapolation from the 59 diagnosed meningoencephalitis cases, the investigators conservatively estimate that the New York outbreak consisted of 8200 (range 3500-13 000) West Nile viral infections, including about 1700 febrile infections. The risk of severe illness was higher among older people, with one case of meningoencephalitis for every 50 infections for those aged 65 years and over, compared with one case for every 300 infections for people aged less than 65 years.

Use of DEET-containing mosquito-repellent was protective of infection in those who spent 2 or more hours outdoors between dusk and dawn, the peak biting period for Culex mosquitoes. However, 70% of residents reported never using mosquito repellent, even after the outbreak was recognised.

Farzad Mostashari comments: "As West Nile virus becomes more established in the northeastern USA and threatens to extend its geographic range in the future, public-health authorities and policy makers should be aware of the entire range of illness caused by West Nile virus. Physicians in communities at risk for West Nile virus disease outbreaks should consider infection with this virus in the differential diagnosis of unexplained summertime fevers, especially if accompanied by headache, muscle ache, and joint pain."

In an accompanying Commentary (p 254) Z Hub'¡lek from the Institute of Vertebrate Biology, Valtice, Czech Republic, compares and contrasts the New York outbreak with other epidemics, notably in central Europe. He comments: "In conclusion the good news for public health is that fewer than 1% of cases of West Nile fever develop into meningoencephalitis. The bad news is that more than 90% of the milder cases are not diagnosed correctly, and that the severity of symptoms and the fatality rate may vary from outbreak to outbreak. The factors influencing the variations should be investigated."






Lancet



Related West Nile Virus Current Events and West Nile Virus News Articles West Nile Virus Current Events and West Nile Virus News RSS West Nile Virus Current Events and West Nile Virus News RSS
On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.

UC Davis researchers identify dominant chemical that attracts mosquitoes to humans
Scientists at the University of California, Davis, have identified the dominant odor naturally produced in humans and birds that attracts the blood-feeding Culex mosquitoes, which transmit West Nile virus and other life-threatening diseases.

What are coral reef services worth? $130,000 to $1.2 million per hectare, per year: experts
Experts concluding the global DIVERSITAS biodiversity conference today in Cape Town described preliminary research revealing jaw-dropping dollar values of the "ecosystem services" of biomes like forests and coral reefs - including food, pollution treatment and climate regulation.

Immune cells predict outcome of West Nile virus infection
Infection with West Nile virus (WNV) causes no symptoms in most people. However, it can cause fever, meningitis, and/or encephalitis. What determines the outcome of infection with WNV in different people has not been determined.

Surgical masks and N95 respirators provide similar protection against influenza
A McMaster University study has found that surgical masks appear to be as good as N95 respirators in protecting health-care workers against influenza.

La Jolla Institute announces 2.0 launch of major database to aid vaccine development worldwide
Key improvements in a major infectious disease database that will aid vaccine development worldwide were unveiled today with the 2.0 launch of the National Institutes of Health-sponsored Immune Epitope Database and Analysis Resource (IEDB).

OHSU scientists partner with others to form center aimed at combating infectious diseases
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.

Field stations foster serendipitous discoveries in environmental, biological sciences
North America's biological field stations have long been home to a rich legacy of research results, scientists say, making them important places for serendipitous discoveries in the biological and environmental sciences.

New wheat disease could spread faster than expected
Both plant and human diseases that can travel with the wind have the potential to spread far more rapidly than has been understood, according to a new study, in findings that pose serious concerns not only for some human diseases but also a new fungus that threatens global wheat production.

New test may help to ensure that dengue vaccines do no harm
As vaccines against a virus that infects 100 million people annually reach late-stage clinical trials this year, researchers have developed a test to better predict whether a given vaccine candidate should protect patients from the infection, or in some cases, make it more dangerous, according to an article just published in the journal Clinical and Vaccine Immunology.
More West Nile Virus Current Events and West Nile Virus News Articles
West Nile Virus (Diseases and Disorders)

West Nile Virus (Diseases and Disorders)
by Melissa Abramovitz (Author)

West Nile virus had never been seen in the Western Hemisphere before 1999. Now, it's everywhere in the United States. Find out more about this new health threat and what's being done about it. (20051001)

Recombitek West Nile 10 Dose (1 mL)

Recombitek West Nile 10 Dose (1 mL)
by Recombitek

Recombitek West Nile Virus Vaccine is recommended for the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus infection. This is Live Canarypox Vector vaccine. Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1ml dose by intramuscular route. For primary vaccination, revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended. This contains 10 Doses: 10 x 1 Dose, Lyophilized 10 x 1 mL, Sterile Diluent Doseage: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1 ml dose by intramuscular route. For primary vaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination...

West Nile Virus [Explicit]

West Nile Virus [Explicit]
Brotha Lynch Hung (Primary Contributor)



Koolatron Guardian Pro Bite Shield 1-Acre Propane Mosquito Trap

Koolatron Guardian Pro Bite Shield 1-Acre Propane Mosquito Trap
by Koolatron

Protect your entire family from disease carrying mosquitoes with the Bite Shield 1 Acre Cordless Mosquito Trap Guardian. This trap uses all of the proven mosquito attractants to draw the annoying and harmful insects away from where your loved one gather.This is an easy to assemble, weatherproof unit, powerful enough to cover a full acre of land.The Cordless Guardian Pro requires the installation of a 20 pound propane tank, sold seperately.Now you can eliminate mosquitoes and control deadly viral diseases carried by mosquitoes and other flies with the Bite Shield range of Mosquito Control Products without harmful pesticides.The Bite Shield MK14 Mosquito Trap Guardian utilizes the documented attractiveness of carbon dioxide (CO2), moisture, body temperature(thermal imaging), color, shape...

Off! Insect Repellent II, Aerosol, Fresh Scent - 15% DEET (no longer unscented), 6 oz

Off! Insect Repellent II, Aerosol, Fresh Scent - 15% DEET (no longer unscented), 6 oz
by OFF!

Provides hours of effective protection from mosquitoes, gnats and biting flies (deer flies, sand flies, stable flies and black flies). Also repels ticks, chiggers and fleas from treated skin and clothing. OFF! Insect Repellent II is not greasy, won't stain and resists perspiration. Sprays upside down too. Contains No CFCs or other ozone depleting substances.

  West Nile Virus
by Catcher



FaceDoctorX Anti-Mosquito Soap, 100 g (3.35 oz)

FaceDoctorX Anti-Mosquito Soap, 100 g (3.35 oz)
by Face Doctor

The new way to stop mosquitoes from biting! Non-Toxic, No side effects, Contains 100% herbal extracts! The unique formula found in this soap was developed by Dr. Archibald of the Australian National Biological Laboratory. It contains 100% herbal extraction. Once you shower with this soap, it will repel mosquitoes from touching your skin. It will also relieve insect bites and itching if you did not use the soap offhand. Active Ingredients Function: Eucalyptus oil: Repel mosquitoes, relieve tired muscles. Citronella oil: mosquito repellent. Menthol: Insect and mosquito repellent, refreshes and revitalizes skin. Lavendula: Represses bacteria, diminishes inflammation. Calendula: Diminishes inflammation, relieves itching. Made in China.

  Protecting Yourself and Your Community From West Nile Virus

x VHS tape

West Nile Virus (Deadly Diseases and Epidemics)

West Nile Virus (Deadly Diseases and Epidemics)
by Jeffrey N. Sfakianos (Author), I. Edward Alcamo (Editor), David Heymann (Editor)

Often a serious illnes, West Nile Virus seems to arise as a seasonal epidemic in North America, beginning in the summer and continuing into the fall.

Giant Microbes - West Nile (West Nile virus) - Plush

Giant Microbes - West Nile (West Nile virus) - Plush
by Giant Microbes

The flood of press coverage isn't for the birds. WNV can send you to the after-life.

© 2009 BrightSurf.com